Linzagolix (Yselty) with hormonal add-back therapy will offer a new at-home treatment option for some women in England with ...

A new daily tablet for endometriosis, called linzagolix (also known as Yselty), has been approved for use on the NHS and is ...

Clinical trials have shown linzagolix significantly reduces both menstrual pain and non-menstrual pelvic discomfort compared ...

Linzagolix will only be available for patients whose previous medical or surgical treatments have been unsuccessful.

A NEW daily pill to treat ‘debilitating and life-limiting’ endometriosis will be rolled on the NHS after getting the green ...

Endometriosis is a chronic condition that occurs when cells similar to those in the lining of the womb grow in other parts of ...

A new at-home pill for endometriosis has been approved for use on the NHS. The once-a-day tablet, called linzagolix but also ...

The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to ...

Relugolix–estradiol–norethisterone (relugolix combination therapy [CT]; Ryeqo, Gedeon Richter) is indicated 'in adult women of reproductive age for symptomatic treatment of endometriosis in women with ...

Androgen deprivation therapy (ADT) is standard for advanced prostate cancer. Relugolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, is the only oral ADT, with limited real-world data ...